Mike Sandoval

Chief Technology Officer

Disruption Labs

Mike has a MS in pharmaceutical sciences from University of Texas at Austin with 14+ years in drug development funding, execution and portfolio strategies. Mike served as President and CEO of XEO Pharmaceuticals, a Contract Research Organization (CRO) helping drug startups and 503A pharmacies support early stage R&D and IND-enabling analytical programs. At Xeris Pharma (NASDAQ (XERS)) Mike led R&D operations & development of novel injectable drug products. He’s named inventor on several drug delivery patents and published 10+ scientific papers. He is co-inventor of Disruption Labs’ lipid encapsulation technologies and leads commercial application at Santé Labs by managing tech transfer and commercial scale manufacturing.

Alexander Ghazvinian

Chief Compliance Officer

SICPA

Ulina Bajraktaraj

Division Enforcement

FINMA | UK

Daniel Gysel

Chief Compliance Officer

Zurich Insurance

Tyler Nielsen

CEO

Sanctions Advisory & Former US Treasury and State Department sanctions expert

Thomas Palmberg

Chief Superintendent

The Swedish Police Authority National Operations Department (NOA) Anti-corrup

13. --

Ross Pudney

First Vice President, Head of Financial Crime Compliance Data & Analytics

Danske Bank